Glucose Viaflo Baxter (Glucose)

Glucose Viaflo Baxter is used in clinical settings where rapid provision of carbohydrate energy is required.

• To maintain blood glucose levels during fasting or prolonged surgery.
• As part of fluid resuscitation in patients with hypoglycemia.
• To provide caloric support in critically ill patients receiving total parenteral nutrition.
• In neonatal intensive care for infants with low blood glucose.
• As a diluent for compatible intravenous medications when glucose is needed as a carrier.
• To assist in the administration of certain electrolytes that require a glucose-containing carrier solution.

When administered intravenously, glucose solutions can be associated with a range of physiological responses that are reported as side effects.

Common

• Transient hyperglycemia that resolves after the infusion ends.
• Mild irritation at the infusion site.
• Electrolyte shifts, particularly a decrease in serum potassium.
• Temporary increase in blood osmolality that normalizes after infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypoglycemia after abrupt discontinuation in patients with impaired glucose regulation.
• Fluid overload in patients with compromised cardiac or renal function.
• Risk of infection if aseptic technique is not maintained during preparation or administration.
• Development of hyperosmolar hyperglycemic state in patients with uncontrolled diabetes.

Glucose Viaflo Baxter should be administered with attention to patient-specific factors and standard infusion safety practices.

• Verify blood glucose concentration before and after infusion to avoid extreme values.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Use a dedicated intravenous line or compatible carrier to reduce incompatibility risks.
• Monitor electrolytes, especially potassium and sodium, during and after administration.
• Avoid rapid bolus administration unless clinically indicated, as it may cause sudden hyperglycemia.
• Document the product name, concentration, and total volume administered in the patient record.

Glucose solutions can interact with other intravenous agents, and certain combinations require special consideration.

Avoid

• Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring.
• Mixing with calcium‑containing solutions that may precipitate calcium gluconate.
• Simultaneous infusion with sodium bicarbonate solutions, which can raise solution pH and cause precipitation.

Use with caution

• Concurrent use with potassium chloride infusions; monitor serum potassium closely.
• Administration alongside diuretics that affect fluid balance; adjust volume as needed.
• Use with medications that have a high osmolarity, as combined osmotic load may increase risk of vascular irritation.
• Use with blood products that require a specific glucose concentration; verify compatibility before mixing.